Adam Feuerstein's Small-Cap Biotech Take Down: "You're Trading Worthless Pieces of Paper"

After he called out pharmaceutical companies CYCC and TNXP over their sketchy valuations while appearing on Benzinga's PreMarket Prep morning show, the Benzinga newsdesk analysts discuss the weight behind biotech commentator Adam Feuerstein's severe comments and why investors might want to pay attention. Subscribe to BenzingaTV for more market updates, trading ideas, and the latest financial news. Listen to PreMarket Prep every morning from 8-9 ET: premarket.benzinga.com/pre-market-show/ And catch archived episodes here: soundcloud.com/bztv You can find full articles and analysis at Benzinga.com. ----- Follow us on Twitter: twitter.com/benzinga Like us on Facebook: facebook.com/Benzinga Connect with us on LinkedIn: linkedin.com/company/benzinga ------ Benzinga is a dynamic financial media outlet that empowers investors with real-time news and unique market analysis. Headquartered in the heart of Detroit, Benzinga provides timely, actionable ideas that help traders and investors navigate even the most uncertain and volatile markets.